Consolidated revenue rose for three consecutive years—KRW 7.17bn in 2023, KRW 11.54bn in 2024, and KRW 18.11bn in 2025—while the operating loss narrowed modestly from KRW -64.90bn to KRW -63.88bn and then KRW -58.60bn over the same period.
The operating margin remained deeply negative but trended less severe, moving from -905.1% (2023) to -553.5% (2024) to -323.6% (2025).
Net loss attributable to owners was KRW -54.41bn in 2023, KRW -65.53bn in 2024, and KRW -62.23bn in 2025, while operating cash flow stayed negative in the range of roughly KRW -44bn to -51bn across all three years.
On a quarterly basis, revenue recognition shows clear seasonality tied to development, acceptance, and mass-production schedules, concentrated in the second half and particularly the fourth quarter.
Revenue fell to just KRW 1.15bn in the third quarter of 2025, widening the operating loss to KRW -19.91bn, before surging to KRW 10.38bn in the fourth quarter, which cut the operating loss sharply to KRW -8.69bn.
In 2026, the company posted first-quarter revenue of KRW 3.57bn with an operating loss of KRW -13.17bn, followed by second-quarter revenue of KRW 6.42bn with an operating loss of KRW -11.15bn.
According to the company's 2026 semi-annual report, first-half revenue reached KRW 9.987bn, up 51.9% from KRW 6.575bn a year earlier, while the operating loss narrowed 20.9% year-on-year to KRW 24.319bn, showing growth and loss reduction occurring simultaneously.
Over the trailing four quarters (Q3 2025 through Q2 2026), the cumulative net loss attributable to owners totaled roughly KRW -52.60bn, an amount that still substantially exceeds annualized revenue.